Article

Clonal Hematopoiesis and the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease

2026-04-14

Abstract excerpt

<h4>Background & Aims</h4> Clonal hematopoiesis of indeterminate potential (CHIP) has been linked to chronic liver disease progression, yet its role across the full spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD), from its initial development to end-stage complications, remains unclear. We aimed to comprehensively investigate the association of CHIP and its major subtypes with both th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f7651471-099f-5f74-ba61-24ff818b3034
DOI: 10.64898/2026.04.13.26350754

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clonal Hematopoiesis and the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseDOI 10.64898/2026.04.13.26350754Read

Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver diseaseSemantic proximity Read

Clonal hematopoiesis and risk of chronic liver diseaseSemantic proximity Read

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in population with MASLDSemantic proximity Read

Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the blockSemantic proximity Read

Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives.Semantic proximity Read

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.Semantic proximity Read

Clonal hematopoiesis of indeterminate potential: a unifying mechanism linking metainflammation and cardiometabolic diseases.Semantic proximity Read

Clonal Hematopoiesis of Indeterminate Potential Refines Cardiovascular Risk Stratification in Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3Semantic proximity Read

Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases.Semantic proximity Read

Clonal hematopoiesis of indeterminate potential: a review of its cardiorenal implications and agingSemantic proximity Read

Clonal hematopoiesis driven by Dnmt3a mutations promotes metabolic disease developmentSemantic proximity Read

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.Semantic proximity Read